# Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

> clinical trial · VERIFIED · 2026-08-04

Status: TERMINATED · Sponsor: Boundless Bio, Inc. · Condition: Breast Cancer

- Company: Boundless Bio, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07408089

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.